Published in Mental Health Business Week, March 26th, 2005
The company was recently issued U.S. patents for a method of measuring cholesterol levels using saliva and for novel Alzheimer disease drug candidates targeting spherons and an Australian patent for the use of statin drugs to treat or prevent Alzheimer disease. As well, a U.S. patent has issued for a new method of creating animal models for Alzheimer disease using the DNA sequence for neural thread protein (NTP) under license to the company from Rhode Island Hospital affiliated with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week